Many people missed the outperformance IBB had after the tech sell-off. Leading again today and now wondering if it can start to outperform again like it did from the coronavirus lows. Still no strong news on the COVID vaccine. Could more money flow here as these companies race for a cure?
Komen:
I've taken some profits on the way up. But really like this company for longer term success, let's see if the market agrees
Komen:
Inverse H&S here could keep runnin'